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uring angiogenic remodeling, Ang-1, the ligand
of Tie2 tyrosine kinase, is involved in vessel
sprouting and stabilization through unclear ef-
fects on nascent capillaries and mural cells. In our study,
we hypothesized that the Ang-1/Tie2 system could cross-
talk with integrins, and be inﬂuenced by the dynamic in-
teractions between extracellular matrix and endothelial
cells (ECs). Here, we show that 
 
 
 
5
 
 
 
1 speciﬁcally sensitizes
and modulates Tie2 receptor activation and signaling, al-
lowing EC survival at low concentrations of Ang-1 and
inducing persistent EC motility. Tie2 and 
 
 
 
5
 
 
 
1 interact
D
 
constitutively; 
 
 
 
5
 
 
 
1 binding to ﬁbronectin increases this
association, whereas Ang-1 stimulation recruits p85 and
FAK to this complex. Furthermore, we demonstrate that
Ang-1 is able to mediate selectively 
 
 
 
5
 
 
 
1 outside-in FAK
phosphorylation. Thus, Ang-1 triggers signaling path-
ways through Tie2 and 
 
 
 
5
 
 
 
1 receptors that could cross-
talk when Tie2/
 
 
 
5
 
 
 
1 interaction occurs in ECs plated on
ﬁbronectin. By using blocking antibodies, we consistently
found that 
 
 
 
5
 
 
 
1, but not 
 
 
 
v
 
 
 
3 activation, is essential to
Ang-1–dependent angiogenesis in vivo.
 
Introduction
 
During vertebrate development, angiogenesis identifies a phase
of remodeling and maturation of the primary capillary plexus
(Yancopoulos et al., 2000). In the adult life, angiogenesis oc-
curs in physiologic and pathologic conditions in which trans-
port of oxygen and nutrients are needed (Folkman, 1995). The
maturation of the vascular network is regulated by extracellular
matrix (ECM) remodeling and by proliferation, survival, apop-
tosis, and motility of endothelial cells (ECs). A balanced acti-
vation of growth factor and adhesive receptors is instrumental
for physiologic remodeling; perturbation of this homeostasis
results in the establishment of a chaotic vasculature (Stupack
and Cheresh, 2002).
Ang-1 is the ligand of the endothelial tyrosine kinase re-
ceptor, Tie2 (Davis et al., 1996). Mice lacking Ang-1 die dur-
ing embryo development (E12.5) showing a poorly remodeled
and mature vasculature with defects in EC adhesion and
spreading to the underlying ECM (Suri et al., 1996). The role
of Ang-1 in adult angiogenesis is controversial. Several investi-
gators have shown that Ang-1 acts as proangiogenic factor,
whereas others have demonstrated the opposite (Suri et al., 1998;
Chae et al., 2000; Hangai et al., 2001; Hawighorst et al., 2002;
Shim et al., 2002; Uemura et al., 2002; Stoeltzing et al., 2003).
However, in vitro Ang-1 promotes a proangiogenic program in
ECs characterized by expression of metalloproteases and plas-
min, and induction of morphogenesis, motility, and survival
(Koblizek et al., 1998; Papapetropoulos et al., 1999; Cascone et
al., 2003a; Das et al., 2003). It recently was demonstrated that
Ang-1 promotes cell adhesion (Arai et al., 2004; Lemieux et
al., 2005), and that this process is mediated by 
 
 
 
5-integrin in
ECs (Carlson et al., 2001). Moreover, the finding that Ang-1
can bind ECM extracts from carcinoma cells (Xu and Yu,
2001) has offered new insights to understand the role of Ang-1
in modulating the angiogenic microenvironment.
Cell adhesion is mediated by integrin heterodimers (Gian-
cotti and Ruoslahti, 1999). Cross-talks between integrins and
growth factor receptors were shown to coordinate biologic pro-
cesses through the regulation of downstream and inside-out sig-
naling pathways (Schneller et al., 1997; Soldi et al., 1999; Byzova
et al., 2000; Sieg et al., 2000; Baron et al., 2002; Lee and Juliano,
2002). Tyrosine kinase receptors and integrins share many down-
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stream effectors. In particular, activated Tie2 recruits p85, phos-
phorylates FAK, and modulates Rho GTPases (Kontos et al.,
1998; Jones et al., 2001; Cascone et al., 2003a), which also partic-
ipate in outside-in integrin signaling (Hood and Cheresh, 2002).
Integrins have crucial roles in angiogenesis (Hodivala-
Dilke et al., 2003) and allow vascular cells to adapt their adhe-
sive machinery to the so-called “provisional” ECM components,
like fibronectin, collagen, and vitronectin, that are exposed by
basement degradation around sprouting vessels (Kalluri, 2003).
Integrins 
 
 
 
v
 
 
 
3, 
 
 
 
v
 
 
 
5, 
 
 
 
2
 
 
 
1, and 
 
 
 
5
 
 
 
1 are up-regulated in
newly formed blood vessels (Max et al., 1997; Kim et al.,
2000b), and 
 
 
 
v
 
 
 
3 and 
 
 
 
v
 
 
 
5 antagonists inhibit in vitro and in
vivo angiogenesis (Brooks et al., 1995; Drake et al., 1995;
Hammes et al., 1996). 
 
 
 
2-blocking antibodies (Abs) inhibit
vascular endothelial growth factor (VEGF)-A–induced angio-
genesis (Senger et al., 1997). Vascular defects are described in
 
 
 
5-null embryoid bodies and teratocarcinomas (Taverna and
Hynes, 2001; Francis et al., 2002); antagonists of the central
cell-binding domain of fibronectin also inhibit angiogenesis
(Kim et al., 2000b). Integrins can exist in different functional
states that regulate their biologic functions (Hynes, 2002). In
vivo integrin activity depends on the extracellular environment;
it has been shown that modulation of ECM concentration and
patterning leads to different cell responses ranging from apop-
tosis to growth and differentiation (Dike et al., 1999).
Here, we hypothesize that Ang-1/Tie2 could mediate dif-
ferent biologic effects under the influence of integrin activity.
We demonstrate that Tie2 and 
 
 
 
5
 
 
 
1 form a constitutive and
specific complex, and that Ang-1/Tie2 system is sensitized by
 
 
 
5
 
 
 
1 engagement to fibronectin. Furthermore, we show that
 
 
 
5
 
 
 
1 function is essential to mediate in vivo Ang-1–dependent
angiogenesis in a chick chorioallantoic membrane (CAM) assay.
 
Results
 
Fibronectin sensitizes Tie2 activation and 
signaling to low Ang-1 concentrations
 
Differently from other tyrosine kinase receptor ligands, Ang-1
does not induce cell proliferation. Instead, it delays EC death
triggered by different cellular stresses by inducing phosphati-
dylinositol 3-kinase (PI3-K)/AKT signaling activation (Kim et
al., 2000a).
We analyzed the influence of the integrin function on Ang-
1–mediated EC survival; plating ECs on ECM largely involved
in angiogenesis, such as fibronectin, collagen I, and fibrinogen,
ligands for 
 
 
 
5
 
 
 
1, 
 
 
 
2
 
 
 
1 and 
 
 
 
1
 
 
 
1, and 
 
 
 
v
 
 
 
3 integrins, respec-
tively. ECs were starved and kept for 24 h in 0.5% FCS in
the presence of increasing concentrations of Ang-1 (Fig. S1 a;
available at http://www.jcb.org/cgi/content/full/jcb.200507082/
DC1). In cells plated on collagen I or fibrinogen, the survival ef-
fect of Ang-1 reached relevant values at 200 ng/ml, and the pla-
teau condition at 500 ng/ml. When fibronectin was used as sub-
strate, Ang-1 was effective at 100 ng/ml and attained the plateau
at 200 ng/ml. These results demonstrated a shift of the dose–
response of EC survival on fibronectin versus lower Ang-1 con-
centration. This effect of fibronectin was not observed when
ECs were stimulated with VEGF-A
 
165
 
 (Fig. S1 b).
Because the dose–response effect of Ang-1 on EC survival
was dependent on ECM components (Fig. S1 a), we analyzed
the effect of specific integrin engagement on Tie2 activation.
To verify if ECM could modify Tie2 phosphorylation dose–
response,  we first established Tie2 phosphorylation in ECs
plated on native ECMs (Fig. 1, a and b). Next, on the basis of
the curve in Fig. 1 b, we stimulated ECs plated on fibronectin,
collagen I, or fibrinogen with an ineffective concentration of
Ang-1 (20 ng/ml), and with a higher dose (100 ng/ml) that trig-
gered a 3.15-fold increase of Tie2 phosphorylation (Fig. 1 c).
ECs plated on collagen I or fibrinogen showed a Tie2 phosphor-
ylation response (Fig. 1, c and d) similar to ECM native condi-
tions (Fig. 1 b). On fibronectin, ECs underwent a marked Tie2
phosphorylation with 20 ng/ml of Ang-1 (4.4-fold increase),
whereas 100 ng/ml was less effective (2.2-fold increase; Fig. 1,
c and d). As control, Fig. 1 g shows that the effect of a concen-
tration of VEGF-A
 
165 
 
that induces a negligible phosphorylation
of VEGF receptor (VEGFR)-2 was not affected by ECM pro-
teins, including fibronectin.
Therefore, EC adhesion to fibronectin specifically al-
lowed Tie2 to be responsive to lower amounts of its ligand. We
then examined p85 phosphorylation that is recruited by acti-
vated Tie2 and mediates PI3-K signaling (Kontos et al., 1998)
during Ang-1–dependent cell survival and motility (Kim et al.,
2000a; Cascone et al., 2003a). Similarly to Tie2, p85 was phos-
phorylated at 20 ng/ml Ang-1 on fibronectin (2.0-fold increase)
and 100 ng/ml on collagen I (1.75-fold increase) or fibrinogen
(1.6-fold increase; Fig. 1, e and f). Therefore, Tie2 activation
and signaling were increased at lower Ang-1 concentrations
when ECs adhered to fibronectin; this was consistent with the
results obtained in cell survival (Fig. S1 a).
 
Tie2 interacts selectively and 
constitutively with 
 
 
 
5
 
 
 
1
 
We investigated whether Tie2 receptor could interact physi-
cally with integrins, in particular with 
 
 
 
5
 
 
 
1, the main fibronec-
tin receptor. Lysates from ECs cultured on native ECM were
immunoprecipitated with anti-
 
 
 
5
 
 
 
1 (AB1950) or anti-
 
 
 
1A
(Fig. 2 a), anti-
 
 
 
2
 
 
 
1 (BHA2.1) or anti-
 
 
 
2
 
 
 
1 (JBS2) (Fig. 2 b),
anti-
 
 
 
v
 
 
 
3 (LM609), or anti-
 
 
 
v
 
 
 
3 (25E11) (Fig. 2 c) Abs and
blotted with anti-Tie2 Ab. Tie2 coimmunoprecipitated with
 
 
 
5
 
 
 
1, but not with 
 
 
 
2
 
 
 
1 or 
 
 
 
v
 
 
 
3 integrins. VEGFR-2 was not
detected in 
 
 
 
5
 
 
 
1 immunoprecipitates (Fig. 2 a). To confirm
further the specificity of the association between Tie2 and
 
 
 
5
 
 
 
1, 
 
 
 
5
 
 
 
1 immunoprecipitates were re-immunoprecipitated
with anti-Tie2 and blotted with anti-Tie2 Ab (Fig. 2 d). How-
ever, Tie2/
 
 
 
5
 
 
 
1 association was not detectable by blotting
Tie2 immunoprecipitation with anti-
 
 
 
5
 
 
 
1 (unpublished data),
as it has been described for other integrin/tyrosine kinase re-
ceptor complexes (Baron et al., 2002; Woodard et al., 1998).
To gain further insights about the specificity of Tie2/
 
 
 
5
 
 
 
1 in-
teraction, CHO lacking (CHO B2) or expressing (CHO B2a27)
 
 
 
5 subunit were transfected transiently with Tie2, and immuno-
precipitated with an anti-
 
 
 
1 Ab (Fig. 2 e). Tie2 coimmunopre-
cipitated with 
 
 
 
1 only in CHO B2a27 cells (Fig. 2 e). Thus, Tie2
interacts selectively and constitutively with 
 
 
 
5
 
 
 
1 and not with
other 
 
 
 
1 heterodimers. Then, we labeled, by biotinylation, cell 
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surfaces of CHO B2 and CHO B2a27 expressing Tie2, and we
re-immunoprecipitated Tie2 from 
 
 
 
1 immunoprecipitates as
above. Biotinylated Tie2 was present only in 
 
 
 
1 immune com-
plexes that were isolated from CHO B2a27 (Fig. 2 f). This
strengthened the specificity of the Tie2/
 
 
 
5
 
 
 
1 interaction and
demonstrating that it occurred at the plasma membrane.
To verify the in vivo association between Tie2 and 
 
 
 
5
 
 
 
1
integrin, we analyzed, by immunofluorescence, the localization
of endogenous 
 
 
 
5
 
 
 
1 integrin subunit and Tie2 in ECs plated
on fibronectin, and let them adhere for 1 h and 30 min (i.e.,
until they started developing typical fibrillary contacts). As
shown in Fig. S2 (available at http://www.jcb.org/cgi/content/
full/jcb.200507082/DC1), most of the endothelial 
 
 
 
5
 
 
 
1 integrin
and Tie2 appear to colocalize at the cell membrane in spotty ar-
eas that are located outside of typical fibrillary contacts. Linear
arrays of Tie2-containing spots also colocalize with some
 
 
 
5
 
 1 positive fibrillary contacts.
In ECs plated on native ECM, we observed that Tie2 is
phosphorylated after 5 min and is active until 1 h of Ang-1 stimu-
lation (unpublished data). To demonstrate that Tie2 sensitization
to low Ang-1 concentration was  5 1-dependent, we stimulated
CHO B2 and CHO B2a27 expressing Tie2 or VEGFR-2 for up to
60 min (Fig. 2, g–l). Ang-1 promoted a higher degree of Tie2
phosphorylation in CHO B2a27 compared with CHO B2 (Fig. 2,
Figure 1.  5 1 engagement influences Tie2 phos-
phorylation and signaling. ECs cultured on native
ECM (a) and (g), or on 5  g/ml fibronectin (FN), 5
 g/ml collagen I (COLL), or 20  g/ml fibrinogen (FB)
(c, e, and g) were stimulated with Ang-1 for 5 min
(a, c, and e) or VEGF-A165 (g) at the indicated con-
centrations, lysed, immunoprecipitated (IP) with either
anti-Tie2 (a and c), anti–VEGFR-2 (g), or anti-p85 (c)
and blotted as indicated. Panels b, d, and f show the
densitometric analysis of a, c, and e, respectively,
and indicate the fold increase of Tie2 or p85 tyro-
sine phosphorylation normalized to the total protein
amount. Values shown are means   SD of five inde-
pendent experiments. In b, statistical significance
(*, P   0.01) is shown for increasing Ang-1 concen-
trations compared with 20 ng/ml Ang-1. In d and f,
statistical significance (*, P   0.01) is shown for
Ang-1–stimulated ECs for the indicated substrate.JCB • VOLUME 170 • NUMBER 6 • 2005 996
g and h). Furthermore, in CHO cells lacking  5, Tie2 phosphory-
lation declined after 15 min (Fig. 2, g and h). The phosphoryla-
tion response of VEGFR-2 to its ligand (Fig. 2, i and l) in the two
cell lines did not exhibit the clear-cut differences that were ob-
served for Tie2; this suggested that  5 1 specifically enhances
and prolongs Ang-1–induced Tie2 phosphorylation.
The Tie2/ 5 1 complex is induced by 
fibronectin and activated by Ang-1
Then we investigated the regulation of Tie2/ 5 1 interaction
in ECs (Fig. 3). When ECs were plated on fibronectin, the
amount of Tie2 coimmunoprecipitated with  5 1 integrin was
remarkably higher than on collagen I or fibrinogen (Fig. 3, a
and b). The ability of fibronectin to increase this interaction
was dose-dependent (Fig. 3 c), whereas Ang-1 stimulation did
not modify the amount of receptor that coimmunoprecipitated
with  5 1 integrin on fibronectin, collagen I, or fibrinogen
(Fig. 3 d and data not depicted). To analyze the signaling activ-
ity of Tie2/ 5 1 interaction, we assessed the recruitment of the
p85 subunit of PI3-K and FAK to the complex. p85 is an effec-
tor of activated Tie2 (Kontos et al., 1998), whereas FAK local-
izes to integrin clusters and participates in the integrin signaling
(Hood and Cheresh, 2002). Tie2 association with fibronectin-
activated   5 1 was not accompanied by the recruitment of
FAK and p85 in the  5 1 immunoprecipitates (Fig. 3 c). EC
stimulation by Ang-1 did not modify Tie2 association with
 5 1, but did increase FAK and p85 recruitment to the com-
plex (Fig. 3 d). Thus,  5 1 occupancy regulates the stoichiom-
etry of Tie2/ 5 1 association, whereas Ang-1 triggers intracel-
lular signals downstream of Tie2/ 5 1 complexes.
It was shown that coated Ang-1 induces CHO B2a27, but
not CHO B2, cell adhesion (Carlson et al., 2001). Therefore, we
tested the hypothesis that soluble Ang-1 could promote  5 1
outside-in signaling in a Tie2-independent way. To exclude inte-
grin engagement, CHO B2 and CHO B2a27 were plated on
poly-lysine and then stimulated with soluble Ang-1, which in-
duced a rapid phosphorylation of FAK in CHO B2a27, but not in
CHO B2, cells (Fig. 3 e). The increase of FAK phosphorylation
Figure 2. Tie2 and  5 1 interact. ECs cul-
tured on native ECM were lysed and immuno-
precipitated by anti- 5 1 (a), anti- 2 1 (b),
or anti- v 3 (c) Abs or control immunoglobu-
lins, and blotted with anti-Tie2 (a–c) or anti- 1
or anti-VEGFR-2 (a) or anti- 2 (b) or anti- 3 (c)
Abs. Anti- 5 1 immunoprecipitates were re-
immunoprecipitated (Re-IP) by anti-Tie2 Ab or
control immunoglobulins and blotted with anti-
Tie2 (d). CHO B2 and B2a27 cells expressing
Tie2 were lysed, immunoprecipitated with
anti- 1 Ab, and blotted with anti-Tie2 Ab (e),
or biotinylated before lysis, Tie2 or control
immunoglobulins re-immunoprecipitated and
revealed by peroxidase-conjugated streptavi-
din (f). CHO B2 and B2a27 cells expressing
Tie2 or VEGFR-2 adhered on poly-lysine
(CHO B2) or on fibronectin (CHO B2a27)
were stimulated with Ang-1 (50 ng/ml) or
VEGF-A165 at the indicated time points; lysed;
and immunoprecipitated with anti-Tie2 or anti-
VEGFR-2 Abs and blotted with anti-phosphoty-
rosine (g and i), anti-Tie2 (g) or anti-VEGFR-2
Abs (i). h and l show the densitometric analy-
sis where the Tie2 or VEGFR-2 tyrosine phos-
phorylation fold increase has been calculated
as described in this legend. Values shown are
means   SD of five independent experiments.
Statistical significance (*, P   0.01) is shown
for Ang-1– or VEGF-A165–stimulated cells com-
pared with unstimulated cells.ACTIVATED  5 1 SENSITIZES TIE2 RECEPTOR • CASCONE ET AL. 997
induced by Ang-1 was similar to that observed when CHOa27
were plated on fibronectin (Fig. 3, e and f). Ang-1–dependent
FAK phosphorylation in CHO B2a27 was not blocked by adding
anti- 5 1 functional blocking mAb (unpublished data); this sug-
gested that Ang-1– and fibronectin-dependent activation of
 5 1 relies upon different molecular mechanisms. These results
suggest that Ang-1 could trigger the signaling of the complex
through Tie2 and  5 1 downstream effector activation.
Ang-1 selectively enhances EC motility 
on fibronectin
We demonstrated previously that Ang-1 promotes EC chemo-
kinesis by increasing their basal locomotion (Cascone et al.,
2003a). We analyzed EC motility on fibronectin, collagen I, and
fibrinogen by time-lapse videomicroscopy experiments in the
presence or absence of Ang-1. Ang-1 (50 ng/ml) greatly in-
creased the basal speed of ECs plated on fibronectin, whereas its
effect was less on cells plated on collagen I and fibrinogen (Fig.
4 a). The net path covered and the migration persistence also
were greater on fibronectin (Fig. 4, b and c). In contrast, Ang-1
did not modify the net path covered and had a slight effect on
cell persistence on collagen I or fibrinogen (Fig. 4, b and c). The
results did not change under increasing Ang-1 concentrations,
independently from the type of substrate (unpublished data). Fig.
4 d shows the tracks of single ECs; this clearly indicates that
Ang-1 stimulated a persistent motility of EC on fibronectin,
whereas on collagen I and fibrinogen, cells moved randomly
around the starting point. As expected (Rousseau et al., 2002;
Serini et al., 2003a) VEGF-A165 was able to increase all chemo-
kinetic parameters studied, but it did not show gains of function
on fibronectin compared with the other ECM components (Fig.
4, a–c); this supported the specificity of Ang-1/Tie2 signaling.
Because we demonstrated that Ang-1 induces PI3-K–
dependent Rac1-GTP modulation necessary to increase EC
basal locomotion (Cascone et al., 2003a), we next looked at the
influence of the different substrates on Rac1 activity. Ang-1,
but not VEGF-A165, triggered a strong and persistent up-regula-
tion of Rac1-GTP in ECs plated to fibronectin. Rac1-GTP
peaked at 2 min and persisted for up to 120 min (Fig. 4, e and
f). This effect of Ang-1 was negligible in cells plated on col-
lagen I or fibrinogen (Fig. 4 e). Therefore, Ang-1 preferentially
promotes directional chemokinesis and Rac1 activation when
ECs are engaged by fibronectin.
To support the chemokinetic results further, we studied
Ang-1 activity in haptotaxis (Fig. S3 a; available at http://www.
jcb.org/cgi/content/full/jcb.200507082/DC1). Ang-1 increased
Figure 3.  Tie2/ 5 1 complex increases
upon  5 1 engagement and transduces upon
Ang-1 stimulation. ECs plated on 5  g/ml fi-
bronectin, 5  g/ml collagen I, and 20  g/ml
fibrinogen (a) or on increasing concentrations
of fibronectin (1–10  g/ml; c), or on 5  g/ml
fibronectin (d) were lysed, immunoprecipitated
by anti- 5 1 Ab. (d) ECs were stimulated by
Ang-1 (50 ng/ml) for 5 min. Blots were
probed as indicated. CHO B2 and B2a27
were plated on poly-lysine or fibronectin (e),
stimulated or not with Ang-1 (50 ng/ml) for
5 min, lysed, immunoprecipitated with anti-
FAK, and blotted with antiphosphotyrosine or
anti-FAK. Densitometric analysis shows the rel-
ative amount of Tie2 in  5 1 immunoprecipi-
tates expressed in arbitrary unit (b) and the
fold increase of FAK phosphorylation (f). Val-
ues shown are means   SD of five indepen-
dent experiments. Statistical significance (*,
P   0.01) is shown for ECs plated on fibronec-
tin compared with the other conditions, and for
Ang-1– or fibronectin-stimulated CHOB2a27
compared with CHO B2.JCB • VOLUME 170 • NUMBER 6 • 2005 998
cell migration toward all the substrates tested in a dose-depen-
dent manner. However, the dose–response effect of Ang-1 to-
ward fibronectin was shifted to the left and reached the plateau
at 50 ng/ml. Ang-1–dependent haptotaxis activity toward col-
lagen I or fibrinogen was less, appeared at 50 ng/ml, and at-
tained the plateau at 100 ng/ml. VEGF-A165 did not showed any
selective effect on EC motility toward fibronectin as compared
with collagen I and fibrinogen (Fig. S3 b).
Ang-1 enhances integrin-mediated
EC adhesion
Growth factor receptors modulate integrin function through
PI3-K–dependent inside-out signaling to mediate enhanced bi-
ologic effects, such as cell motility, survival, and invasion
(Guilherme et al., 1998; Byzova et al., 2000; Baron et al.,
2002). Therefore, we verified if the Ang-1–enhanced effect on
fibronectin involved selective  5 1 inside-out activation. Then
we performed adhesion assays of ECs to fibronectin, collagen I,
fibrinogen (Fig. 5), and vitronectin (not depicted) in the pres-
ence or absence of Ang-1. Surprisingly, adhesion assays with
different concentrations of Ang-1 and ECM proteins showed
that Ang-1 increased EC adhesion to a similar extent, indepen-
dently from the engaged integrins. The highest increase was
observed at 50 ng/ml of Ang-1 in ECs adhering on 5  g/ml of
fibronectin or collagen I and 20  g/ml of fibrinogen (Fig. 5, a, c,
and e). Function blocking anti- 5 1 (Fig. 5 b), anti- 2 1 (Fig.
5 d), and anti- v 3 (Fig. 5 f) mAbs impaired Ang-1–increased
EC adhesion to fibronectin, collagen I, and fibrinogen, respec-
tively; this demonstrated that Ang-1–mediated adhesion was
integrin-dependent. Because  v 3 promotes RGD-mediated
cell adhesion (Arnaout et al., 2002), anti- v 3 mAb partially
inhibited basal EC spreading, but did not block Ang-1–mediated
Figure 4. Ang-1 increases the speed and the persistence
of EC plated on fibronectin. Starved ECs were plated on
5  g/ml fibronectin (FN), 5  g/ml collagen I (COLL),
and 20  g/ml fibrinogen (FG) for 1 h and stimulated or
not with 50 ng/ml of Ang-1 or 10 ng/ml of VEGF-A165.
Time-lapse videomicroscopy was performed and recorded
images every 5 min for 4 h. 50 cells from five different
videos were examined for speed (a), net path length cov-
ered (b), and persistence (c; deg, direction). (d) ECs
paths were tracked over 4 h and replotted such that all
paths start from origin. Values shown are means   SD of
50 cells from five independent experiments. Statistical
significance is shown (*, P   0.01 and 
§, P   0.05) for
stimulated cells compared with unstimulated cells; 
••, P  
0.01 for Ang-1–stimulated cells compared with VEGF-
A165–stimulated cells. ECs plated as in (a) were stimulated
with 50 ng/ml of Ang-1 (e) or 10 ng/ml of VEGF-A165 (f)
for the indicated times, and cell lysates were incubated
with GST-PBD to pull-down Rac1-GTP. Proteins separated
by SDS-PAGE were probed with anti-Rac1 Ab. This ex-
periment is representative of five experiments performed
with similar results.ACTIVATED  5 1 SENSITIZES TIE2 RECEPTOR • CASCONE ET AL. 999
adhesion to fibronectin (Fig. 5 b and not depicted). The PI3-K–
specific inhibitor, LY294992, affected Ang-1 proadhesive ac-
tivity on all ECM ligands (Fig. 5, b, d, and f); this indicated that
PI3-K plays a role in this Tie2-dependent inside-out signaling.
The role of Tie2 activation in EC adhesion induced by soluble
Ang-1 also was investigated in porcine aortic ECs (PAE cells)
that were transfected with Tie2 (PAE-Tie2) or with the mutant
Tie2-K854R (PAE-Tie2-K854R), which lacks the catalytic ac-
tivity (Audero et al., 2004; Fig. 5 g). PAE-Tie2-K854R did not
support Ang-1–dependent increased adhesion, which further
suggested that this process was Tie2 dependent.
Integrin  5 1 is necessary for in vivo 
Ang-1–induced angiogenesis
Next, we investigated the role of  5 1 integrin in Ang-1–
mediated in vivo angiogenesis. Filter disks saturated with saline
or Ang-1 were applied to 10-d-old embryo CAMs. 24 h later,
CAMs were treated with function-blocking anti- 5 1 or anti-
Figure 5. Ang-1 induces EC adhesion through specific
integrin function. Panels a, c and e show the fold in-
crease of EC adhesion induced by Ang-1 (20, 50, 100
ng/ml) versus unstimulated ECs to different concentra-
tions of fibronectin (a), collagen I (c), or fibrinogen (e).
Values shown are means   SD of five independent exper-
iments, each in triplicate. Statistical significance (*, P  
0.01, 
§, P   0.05) is shown for increasing Ang-1 concen-
trations compared with 20 ng/ml Ang-1. b, d, and f
show the fold increase of EC adhesion induced by Ang-1
(50 ng/ml) to 5  g/ml fibronectin (b), 5  g/ml col-
lagen I (d), or 20  g/ml fibrinogen (f) in the presence of
function-blocking anti- 5 1 (JBS5), anti- v 3 (LM609),
or anti- 2 1 (BHA2.1) Abs, or LY294002. Statistical sig-
nificance (
§, P   0.01) is shown for Abs and LY294002
treatment compared with untreated control. PAE-Tie2 and
PAE-Tie2-K854R fold increase adhesion to 5  g/ml fi-
bronectin induced by Ang-1 (50 ng/ml) (g). Values
shown are means   SD of five independent experiments.
Statistical significance (*, P   0.01) is shown for PAE-
Tie2-K854R compared with PAE-Tie2.JCB • VOLUME 170 • NUMBER 6 • 2005 1000
 v 3 or anti-fibronectin cell binding peptide mAbs (anti-
CBP), which were reported to inhibit growth factor–dependent
angiogenesis without affecting preexisting vessels (Brooks et
al., 1994; Kim et al., 2000b). 2 d later, CAMs were excised and
pictures of filter disks were taken (Fig. 6, a–f; see Supplemen-
tal methods). Ang-1 promoted vessel branching and remodel-
ing as compared with saline treatment (Fig. 6, a, b, and i). Anti-
 5 1 (Fig. 6 d) and anti-CBP (Fig. 6 e) completely abrogated
Ang-1–induced angiogenesis, whereas immunoglobulin treat-
ment was ineffective (Fig. 6, c and i). mAb anti- v 3 (Fig. 6, f
and i) only partially inhibited the effect of Ang-1 that main-
tained a significant angiogenic index versus saline treatment.
These results demonstrate that  5 1 plays a major role in
Ang-1–mediated in vivo vascular remodeling and sprouting.
Discussion
Angiogenesis involves dynamic remodeling of the environment
surrounding blood vessels through ECM degradation and depo-
sition of new components. Recent works highlighted the impor-
tance of the synergy of signals provided by ECM and growth
factors transduced by integrins and specific receptors (Miyamoto
et al., 1996; Decker and ffrench-Constant, 2004; Goel et al.,
2004). During angiogenesis, integrins are involved in new blood
vessel formation as witnessed by studies with integrin antago-
nists and generation of null mice (Hodivala-Dilke et al., 2003).
Moreover, the interaction of  v 3 with VEGFR-2 may mediate
enhanced growth factor–induced cellular response (Soldi et al.,
1999; Borges et al., 2000). In this study, we describe the inter-
action of endothelial receptor Tie2 and  5 1, and suggest a
new paradigm of angiogenesis modulation that could parallel
VEGFR-2/ v 3 cross-talk. The association between Tie2 and
 5 1 is constitutive and regulated through  5 1 engagement by
fibronectin; it results in the sensitization of the receptor to low
Ang-1 concentrations and in the acquisition of an efficient direc-
tional motility. Furthermore, we demonstrate that  5 1 activa-
tion is necessary in the in vivo angiogenic response to Ang-1.
Integrin occupancy may cause growth factor receptor auto-
phosphorylation (Moro et al., 1998), and several data demon-
strate that growth factor receptors and integrins associate under
growth factor stimulation (Woodard et al., 1998; Soldi et al.,
1999; Lee and Juliano, 2002) or under integrin activation (Ben-
ingo et al., 2001; Baron et al., 2002). In ECs, Tie2 is present in
free-form and associated with  5 1 integrin. The activation of
 5 1 integrin by fibronectin increases the complex with Tie2
and modulates the time and concentration window of the receptor
activation. When  5 1 is activated, Tie2 is phosphorylated at
low Ang-1 concentrations, whereas at higher Ang-1 concentra-
tions the activation is attenuated. Moreover,  5 1 expression in-
fluences the duration of Ang-1–dependent Tie2 phosphorylation.
Therefore, we may speculate that  5 1 activation could influ-
ence Tie2 signal duration and signal strength. It has been reported
how the quantitative modulation of signal threshold of tyrosine
kinase receptors affects the biologic outcome (Hunter, 2000).
Figure 6.  5 1 is essential for Ang-1–mediated angio-
genesis in CAM assay. Filter disks saturated with saline
(a), Ang-1 (b), Ang-1 treated with control immunoglobu-
lins (c), anti- 5 1 (JBS5; d), anti-CBP (784A2A6; e), and
anti- v 3 (LM609; f) Abs. The vessel pattern (g) and forks
(h) were analyzed by the imaging software winRHIZO
Pro. (i) Measurement of forks/mm
2 by the imaging soft-
ware winRHIZO Pro. Values shown are means   SD of five
independent experiments, each in triplicate. Statistical
significance (*, P   0.01) is shown for Ang-1 treatment
compared with control and (
§, P   0.01) for Abs treat-
ment compared with Ang-1 stimulation.ACTIVATED  5 1 SENSITIZES TIE2 RECEPTOR • CASCONE ET AL. 1001
It has been suggested that cooperation between integrins
and growth factor receptors may be due to the formation of a
complex between FAK and the cytosolic domain of the recep-
tor tyrosine kinase (Sieg et al., 2000). Alternatively, it may in-
volve the direct interaction of the receptors (Borges et al.,
2000). Our data show that Tie2 and  5 1 association occurs in-
dependently from cell adhesion and  5 1 activation. Fibronectin-
mediated  5 1 activation up-regulates the constitutive basal
level of Tie2/ 5 1 interaction without increasing FAK in the
complex. Therefore, these evidences suggest that Tie2 and
 5 1 complex independently from the presence of a FAK-
mediated intracellular bridge, and that this association should
be direct, as reported for the interaction between VEGFR-2
and  v 3 (Borges et al., 2000) and further stabilized by con-
formational changes occurring during integrin activation.
Peculiarly, Ang-1 does not modify the features of asso-
ciation between Tie2 and fibronectin-engaged  5 1, but trig-
gers biochemical signals that recruit p85 and FAK to the
complex. It is known that p85 binds activated Tie2 (Kontos
et al., 1998), whereas FAK is recruited to the cytosolic tail
of clusterized integrins at the focal adhesions (Schlaepfer
and Mitra, 2004). Thus, Ang-1 stimulation mediates Tie2 and
 5 1 signaling, and allows a cross-talk between these path-
ways by acting at the level of Tie2/ 5 1 complex. Integrins
respond to intracellular cues by modifying the avidity for
their ligands. Growth factor receptors modulate integrin func-
tion through inside-out signaling to mediate enhanced bio-
logic effects, such as cell motility, survival, and invasion
(Byzova et al., 2000; Guilherme et al., 1998; Baron et al.,
2002). Here, we demonstrate that Ang-1/Tie2 activates inte-
grins through the PI3-K signaling which suggests that FAK
recruitment to Tie2/ 5 1 complex could be dependent on ac-
tivated Tie2 inside-out signaling. Conversely, the observation
that immobilized (Carlson et al., 2001) or soluble Ang-1
binds and activates  5 1 in the absence of Tie2 demonstrates
that Ang-1 promotes  5 1 outside-in signaling. Therefore, all
together the results suggest a model in which the synergism
of Tie-2/ 5 1 inside-out/outside-in signaling would allow
the stabilization of the complex and the activation of Tie2 at
lower Ang-1 concentrations. Furthermore, increased Tie2/
 5 1 interaction on fibronectin promotes selective signaling
pathways that modify the chemokinetic response of ECs to
Ang-1 with the appearance of a directional motility.
We demonstrated previously that EC chemokinesis medi-
ated by Ang-1 on native ECM is characterized by two peaks of
Rac-1 activation that are PI3-K dependent (Cascone et al.,
2003b). In this study, we report that Ang-1 induces a prolonged
Rac1 activation over a 2-h stimulation in ECs adhered to fi-
bronectin, but not to other ECM molecules. Rac1-GTP medi-
ates lamellipodia extension at the leading edge and participates
in growth factor receptors and integrin signaling pathways
(Cho and Klemke, 2002; Burridge and Wennerberg, 2004).
Furthermore,  1 integrin overexpression increases Rac activity
(Miao et al., 2002), and PI3-K/Rac1 loop exerts a positive role
in directed motility (Wang et al., 2002); this suggests that
Tie2/ 5 1 cross-talk may enhance Ang-1–dependent Rac1
up-regulation, and thus, promote persistent motility.
 5 1 integrin normally is expressed in ECs and is up-
regulated during angiogenesis, whereas fibronectin is highly
synthesized during embryonic and tissue remodeling and in
injured tissues (Armstrong and Armstrong, 2000). Genetic ab-
lation of  5 or fibronectin leads to embryonic lethality with
major vascular defects (George et al., 1993; Yang et al., 1993)
and Abs or peptides that block  5 1 function inhibit growth
factor–induced angiogenesis (Kim et al., 2000b). Knock-out
mice for Ang-1 or Tie2 show severe defects in vascular remod-
eling, branching, and maturation (Sato et al., 1995; Suri et al.,
1996). Ang-1 has angiogenic effects in many models of postna-
tal angiogenesis, such as retinal vascularization (Uemura et al.,
2002) and hindlimb and myocardial ischemia (Shyu et al.,
1998; Chae et al., 2000). In other experimental models, Ang-1
exclusively acts in enhancing VEGF-mediated angiogenic ef-
fects (Asahara et al., 1998; Zhu et al., 2002). The role of Ang-1
in tumor angiogenesis seems to be correlated strictly with the
tumor model analyzed (Metheny-Barlow and Li, 2003), and is
proangiogenic (Shim et al., 2002; Machein et al., 2004) and an-
tiangiogenic (Hawighorst et al., 2002; Stoeltzing et al., 2003).
In this study, we show that Ang-1 induces vessel remodeling in
CAM assay, and that this process depends on  5 1 integrin
and the cell-binding domain of fibronectin, but not on  v 3 in-
tegrin. Interestingly, in the same in vivo model, antagonists of
 5 1 integrin blocked bFGF-, TNF- –, and IL-8–stimulated
angiogenesis, but had a minimal effect on VEGF-A response
(Kim et al., 2000b). These evidences indicate that Ang-1 elicits
angiogenesis through a strict cooperation with activated  5 1
integrin. Functional cross-talk between Tie2 and  5 1 is high-
lighted by similarities in the defects of heart development in
mice that were genetically modified for  5 and Ang-1 or Tie2
(Yang et al., 1993; Dumont et al., 1994; Suri et al., 1996).
Expression of  5 1 in ECs correlates with angiogenesis, and is
engaged in ECM remodeling sites where fibronectin and other
ECM components accumulate to mediate dynamic interactions
with activated ECs (Kalluri, 2003). Recently, Thurston et al.
(2005) described how Ang-1 promotes the enlargement of ves-
sels in a critical window of vascular plasticity in neonatal mice.
Therefore, we point out that Ang-1/Tie2 biologic effects could
be regulated by microenvironment changes that characterize
the angiogenic switch occurring in tissues. In conclusion, we
demonstrate that Tie2 and  5 1 structurally and functionally
cross-talk in vitro and in vivo, and lead to a fine-tuning modu-
lation of the vascular effect of Ang-1.
Materials and methods
Cell culture and reagents
Human umbilical vein ECs were cultured and used as described previously
(Bussolino et al., 1992). PAE cells (provided by J. Waltenberger, University
Medical Center, Ulm, Germany) constitutively expressing human Tie-2 or
human Tie2-K854R were cultured as described (Audero et al., 2004).
CHO clone B2 cell line expressing  2% of endogenous hamster  5/ 1
and CHO clone B2/a27 expressing pECE- 5 were provided by R. Juliano
(University of North Carolina, Chapel Hill, NC; Bauer et al., 1993). In
some experiments, CHO B2 and B2/a27 were transfected with pCDNA3-
Tie2, or pCDNA3-VEGFR-2 provided by Georg Breier (Max Planck Insti-
tute for Physiological and Clinical Research, Bad Nauheim, Germany).
Cells were cultured on wells or transwells (Costar) or dishes (Falcon)
coated with fibronectin, collagen I, or fibrinogen at the indicated concen-JCB • VOLUME 170 • NUMBER 6 • 2005 1002
trations, and saturated with 3% BSA. Human recombinant Ang-1 and
VEGF-A165 were from R&D Systems.
For the antibodies used, see online supplemental materials (avail-
able at http://www.jcb.org/cgi/content/full/jcb.200507082/DC1).
Adhesion assay
ECs and PAE cells were starved in 0.5% FCS. 100 cells/ l were plated in
the presence of Ang-1 on 96-well microtiter plates, incubated for 30 min
at 37 C, washed three times with PBS, fixed in 3.7% glutaraldehyde, and
stained with 0.1% crystal violet. In some experiments, JBS5 anti- 5 1
(2  g/ml), LM609 anti- v 3 (2  g/ml), BHA2.1 anti- 2 1 (5  g/ml)
Abs (Chemicon), or LY294002 (15  M) were added to cell suspension.
This drug concentration did not modify cell viability as assessed by trypan
blue exclusion. The absorbance was read at 540 nm in a spectrophotom-
eter for microtiter plate (HT6 7000 Bio Assay Reader, PerkinElmer).
Motility assay
Starved ECs were plated onto 20-mm dishes and allowed to adhere in
0.5% FCS for 1 h at 37 C. Ang-1 or VEGF-A165 was added to the me-
dium, and ECs were observed with an inverted microscope equipped with
thermostatic and CO2 controlled chamber (model DM IRB HC; Leica).
Phase-contrast video images of control and stimulated ECs were recorded
at 5-min intervals for 4 h using a CCD camera (Hamamatsu Photonics),
and were analyzed for velocities of cell migration, path length covered,
and directionality of cell motility using DIAS image processing software
(Solltech) as described previously (Serini et al., 2003b). Speed, net path
length, and persistence parameters of 50 cells from five experiments were
calculated and plotted.
Immunoprecipitation
Cells were washed with cold PBS and lysed in buffer with added protease
and phosphatase inhibitors (50  g/ml pepstatin, 50  g/ml leupeptin, 10
 g/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, 100  M ZnCl2, 1 mM
Na3VO4). To immunoprecipitate integrin complexes, a buffer containing
50 mM HEPES (pH 7.4), 5 mM EDTA, 2 mM EGTA, 150 mM NaCl, 10%
glycerol, and 1% NP-40 was used. For all of the other conditions of immu-
noprecipitation, a buffer containing 10 mM Tris-HCl pH 7.5, 150 mM
NaCl, 5 mM EDTA, 1% Triton X-100, 10% glycerol was used. In some ex-
periments, cells were labeled for detection of cell surface proteins (ECL
Protein Biotinylation Module, Amersham Biosciences), washed three times
with ice-cold PBS, and incubated with bicarbonate buffer containing bio-
tinamidocaproato N-hydroxysuccinamide ester for 30 min at 4 C before ly-
sis. Lysates (1 mg) were precleared with nonimmune goat serum or mouse
IgG and protein G-Sepharose (Amersham Biosciences) for 2 h at 4 C and
then incubated with protein G-Sepharose or protein A-Sepharose and Abs
indicated for 2 h at 4 C. In re-immunoprecipitation experiments, the im-
mune complexes from anti- 5 1 immunoprecipitation were resuspended
in 50 mM Tris-HCl pH 7.4, 2% SDS and heated for 5 min at 95 C. Super-
natants were diluted 10-fold with lysis buffer and immunoprecipitated with
anti-Tie2 Ab. After washes, immunoprecipitates were resolved on SDS-
PAGE, immunoblotted as indicated or probed with peroxidase-conjugated
streptavidin, and detected by the enhanced chemiluminescence technique
(PerkinElmer). Densitometry represent the results of at least five indepen-
dent experiments.
Chick CAM angiogenesis assays
For CAM assay, we produced some changes to the previously described
method (Valdembri et al., 2002). Fertilized chick embryos were incubated
for 3 d at 37 C at 70% humidity. A small hole was made over the air sac
at the end of the egg and a second hole was made directly over the em-
bryonic blood vessels. After 10 d, cortisone acetate–treated filter disks
(5 mm) saturated with 50–200 ng of Ang-1 or saline were placed on the
CAM in an area with a minimum of small blood vessels. The day after,
anti- 5 1 (JBS5; 15  g), anti- v 3 (LM609; 10  g), or anti (anti-CBD;
784A2A6; 25  g) function-blocking Abs or IgG (25  g) was applied on
the filter disks, and eggs were incubated for 2 d. The concentrations were
chosen based on previously published experiments (Kim et al., 2000b).
CAM analysis
CAMs were fixed with PBS-3.7% paraformaldehyde for 10 min at room
temperature, filter disks were excised, and pictures were taken with a JVC
TK-C1380E color video camera (ImageProPlus 4.0 imaging software) con-
nected to the stereomicroscope (model SZX9; Olympus). Pictures were
processed with the imaging software winRHIZO Pro (Regent Instruments
Inc.). This software reproduces vessel pattern (Fig. 6 g), identifies vessel
branching, and gives back the forks (blood vessel branch points) pro area
(arrows in Fig. 6 h). Data represent the results of five independent experi-
ments, each performed in triplicate.
Statistical analysis
Statistical analysis was performed using the unpaired t test or one-way
analysis of variance and Bonferroni’s test for pairwise multiple compari-
sons (SSPS 13.0; SPSS Inc.).
Online supplemental material
Fig. S1 shows EC survival data. Fig. S2 shows the colocalization of Tie2
and  5 1. Fig. S3 shows haptotaxis data. Online supplemental material
available at http://www.jcb.org/cgi/content/full/jcb.200507082/DC1.
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